Report overview
Ophthalmic Steroids Drugs refer to the steroids drug for the Ophthalmic. A large class of important natural compounds are derived from steroids with a tetracyclic structure. These compounds are called steroids and they are found in all plants and animals. The most abundant steroid in animals is cholesterol C27H46O. The body can synthesize cholesterol, and it can easily absorb cholesterol from food through the intestinal wall. Cholesterol is related to the formation of gallstones, which also harden the arteries. Biochemical changes and degradation of cholesterol produce many steroids that are important in human biochemistry.
This report aims to provide a comprehensive presentation of the global market for Ophthalmic Steroids Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ophthalmic Steroids Drug. This report contains market size and forecasts of Ophthalmic Steroids Drug in global, including the following market information:
Global Ophthalmic Steroids Drug Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Ophthalmic Steroids Drug Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Ophthalmic Steroids Drug companies in 2023 (%)
The global Ophthalmic Steroids Drug market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Uveitis Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Ophthalmic Steroids Drug include Bausch and Lomb, Alimera Sciences, Allergan, Novartis AG, GlaxoSmithKline, Genentech, Pfizer, Bayer AG and Regeneron Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
We surveyed the Ophthalmic Steroids Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ophthalmic Steroids Drug Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Ophthalmic Steroids Drug Market Segment Percentages, by Type, 2023 (%)
Uveitis
Diabetic Macular Edema
Allergic Conjunctivitis
Keratitis
Others
Global Ophthalmic Steroids Drug Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Ophthalmic Steroids Drug Market Segment Percentages, by Application, 2023 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Research Institute
Others
Global Ophthalmic Steroids Drug Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Ophthalmic Steroids Drug Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ophthalmic Steroids Drug revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Ophthalmic Steroids Drug revenues share in global market, 2023 (%)
Key companies Ophthalmic Steroids Drug sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Ophthalmic Steroids Drug sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bausch and Lomb
Alimera Sciences
Allergan
Novartis AG
GlaxoSmithKline
Genentech
Pfizer
Bayer AG
Regeneron Pharmaceuticals
Valeant Pharmaceuticals International
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ophthalmic Steroids Drug, market overview.
Chapter 2: Global Ophthalmic Steroids Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Ophthalmic Steroids Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ophthalmic Steroids Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Ophthalmic Steroids Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
